Skip to content

Neuromodulation-Induced Cortical Prehabilitation in High Grade Glioma Near the Motor Pathway: Cortical Plasticity Assessed by Navigated Transcranial Magnetic Stimulation (nTMS)

Neuromodulation-Induced-Cortical-Prehabilitation In High Grade Glioma Close To The Motor Pathway: Analysis Of The Cortical Brain Plasticity Through Navigated Transacranial Magnetic Stimulation

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07471100
Enrollment
63
Registered
2026-03-13
Start date
2026-04-01
Completion date
2030-03-31
Last updated
2026-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumor Adult, Glioma, Glioma, High Grade

Keywords

prehabilitation, neuromodulation, brain plasticity, cortical plasticity, rTMS, nTMS, physical therapy

Brief summary

The goal of this clinical trial is to learn whether Neuromodulation-Induced-Cortical-Prehabilitation (NICP)-using physical therapy (constraint-induced movement training, CIM) alone or combined with repetitive transcranial magnetic stimulation (rTMS)-can promote motor-cortex neuroplasticity before surgery in adults with high-grade gliomas near the motor pathway. It will also learn about the feasibility and safety of these prehabilitation strategies around the time of surgery. The main questions it aims to answer are: 1. Does CIM (with or without rTMS) produce measurable motor-cortex plasticity from baseline to pre-surgery as assessed by neuronavigated TMS (nTMS)? 2. Does adding rTMS to CIM lead to greater neuroplastic changes than CIM alone? 3. What clinical, radiological, and neurophysiological outcomes are observed after surgery in participants who receive prehabilitation compared with controls? Researchers will compare standard care (control) vs CIM-based physical therapy vs CIM plus rTMS to see if these approaches induce preoperative neuroplastic changes that may support better surgical outcomes. Participants will: 1. Be randomized to one of three groups: control, CIM physical therapy, or CIM + rTMS• Undergo nTMS motor mapping and excitability testing at baseline (T0) and the day before surgery (T1) 2. Undergo planned tumor surgery (according to standard methods of care) and complete postoperative clinical, imaging, and neurophysiological follow-up assessments.

Detailed description

Background. The Neuromodulation-Induced-Cortical-Prehabilitation (NICP) is a groundbreaking idea to promote plastic brain changes and, theoretically, to increase the Extent of Resection in brain gliomas improving the surgical outcomes. Moreover, given the infiltrative nature of brain gliomas, NICP could be consistently worthwhile for the patient's clinical outcome, reducing the likelihood of premeditated neurologic sequelae and/or the time-to-recovery during the post-surgical rehabilitation. Hypothesis, Research Need. Up to date only small case series have analysed NICP-induced neuroplasticity, complicating data interpretation. Our study aims to thoroughly measure through neuronavigated Transcranial-Magnetic-Stimulation (nTMS) the plastic brain changes of Physical Therapy (in particular Constraint-Induced-Movements - CIM), repetitive-TMS (rTMS) and the combination of these two techniques in high-grade gliomas (HGGs) close to the motor pathway before surgery to improve surgical outcomes for the benefit of the patient. Methodology. This is a multi-center, prospective, randomized pilot trial. The patients are randomized in 3 groups (A. Control Group, B. Physical Therapy Group, C. Physical Therapy+rTMS Group; randomization 1:2:2). The participants undergo motor cortex analysis through nTMS at the baseline - T0 - and the day before surgery - T1. Postoperative clinical, radiological and neurophyisiological outcomes are also gathered. Patient Enrolment: * Department of Neurosurgery, Hospital of Bolzano (SABES-ASDAA), Bolzano, Italy * Department of Neurosurgery, Azienda Ospedaliera Universitaria Integrata (AOUI) di Verona, Italy Data analysis: * Department of Neurosurgery, Hospital of Bolzano (SABES-ASDAA), Bolzano, Italy * Center for Mind/Brain Sciences - CIMEC, University of Trento, Italy * Department of Neurorehabilitation, Hospital of Vipiteno, SABES-ASDAA), Vipiteno, Italy Analysis Tools: 1. Measurement of neuroplasticity with TMS(Nextim NBS System 5 in Bolzano/EbNeruo STM9000 in Verona). Cortical changes in motor representations will be addressed with:a) nTMS mapping of the motor cortex representations (MEP amplitude and waveforms) on individual anatomical imagesb) 2. Single-pulse indexes of motor cortical excitability: * Cortical Silent Period * Recruitment Curve * Resting Motor Threshold (and intehemispheric ratio) 3. Dual-pulse measures of cortical excitability: * Short-latency intracortical inhibition/facilitation * Short-latency afferent inhibition Expected Outcomes. The investigators don't expect any variation in cortical neuroplasticity between T0 and T1 in group A. On the contrary, The investigators expect a variation in group B, in group C and in group B vs. C.

Interventions

PROCEDUREPhysical Therapy

Physical Therapy protocol for the 10 days preceding surgery: 6h/day Constraint Induced Movement - CIM (immobilization of the ipsilesional hand - unaffected side) + 1h twice a day of fine motor skills focused exercises (e.g. 9-hole peg test) on the controlateral hand (affected side)

Repetitive Transcranial Magnetic Stimulation protocol for the 10 days preceding surgery: This will be done following standard protocols mediated from the protocols for motor and language function in stroke, i.e, daily sessions of 1Hz rTMS for 20 minutes applied to the contralesional hemisphere. • Physical Therapy protocol for the 10 days preceding surgery: 6h/day Constraint Induced Movement - CIM (immobilization of the ipsilesional hand - unaffected side) + 1h twice a day of fine motor skills focused exercises (e.g. 9-hole peg test) on the controlateral hand (affected side)

Sponsors

Azienda Sanitaria dell'Alto Adige
Lead SponsorOTHER
Università degli Studi di Trento
CollaboratorOTHER
Azienda Ospedaliera Universitaria Integrata Verona
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

This is a multi-center, prospective, randomized pilot trial. The patients are randomized in 3 groups (eandomization 1:2:2): A. Control Group, B. Physical Therapy Group, C. Physical Therapy+rTMS Group

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18-80 2. Suspect of High Grade Glioma in MRI 3. Any case of cortical/subcortical HGG radiologically close to Motor Pathway and, thus, where intraoperative monitoring assistance is usually required 4. Preservation of motor function (at least ≥ 3 according to Medical Research Council classification) 5. Signed informed Consent

Exclusion criteria

1. Refusal to Study participation 2. Multifocal/Bilateral Disease

Design outcomes

Primary

MeasureTime frameDescription
Measurement of neuroplasticity with nTMSFrom the date of randomization until the date of surgery, assessed up to 15 daysCortical changes in motor representations will be addressed with Neuronavigated TMS mapping of the motor representations (MEP amplitude and waveforms) of the cortical surface of the peri-Rolandic region on individual anatomical images (Nextim NBS System 5 in Bolzano/EbNeruo STM9000 in Verona). We will consider as primary outcome variable the extension of the cortical surface from which MEPs can be obtained by neuronavigated TMS on the affected hemisphere during the procedure of neuronavigation. This index will be calculated quantitatively as surface area, on the flattened cortical surface, and on the "density" of MEP amplitude on such surface. In addition, we will carry out a quantitative analysis of how many excitable points are present in different cortical regions, by applying the cortical atlas by Glasser et al. (2016) to the patient's brain. In this way we will also be able to quantify the extension of excitable points to the premotor or even non-motor cortical regions.
Measurement of neuroplasticity with TMSFrom the date of randomization until the date of surgery, assessed up to 15 days1. Single-pulse indexes of motor cortical excitability (unit of measure milli Volt - mV): * Cortical Silent Period (CSP) * Recruitment (input-output) Curve (RC) * Resting Motor Threshold (rMT) and intehemispheric rMT ratio (rMT ratio) 2. Dual-pulse measures of cortical excitability (Adimensional; they are MEP-derived ratios . MEP amplitudes are measured in mV).): * Short-latency intracortical inhibition/facilitation (SICI and SICF) * Short-latency afferent inhibition (SAI)

Secondary

MeasureTime frameDescription
Measurement of neuroplasticity with TMS (after surgery)At 1 month and 3 months after surgeryCortical changes in motor representations will be addressed with: Neuronavigated TMS mapping of the motor representations (MEP amplitude and waveforms) of the cortical surface of the peri-Rolandic region on individual anatomical images (Nextim NBS System 5 in Bolzano/EbNeruo STM9000 in Verona)
Measurement of neuroplasticity with TMSAt 1 month and 3 months after surgery1. Single-pulse indexes of motor cortical excitability (measured in mV): Cortical Silent Period (CSP) Recruitment (input-output) Curve (RC) Resting Motor Threshold (rMT) and intehemispheric rMT ratio (rMT ratio) 2. Dual-pulse measures of cortical excitability (Adimensional; they are MEP-derived ratios - MEP amplitudes are measured in mV): Short-latency intracortical inhibition/facilitation (SICI and SICF) Short-latency afferent inhibition (SAI)

Contacts

CONTACTPier Paolo Berti, MD, PhD(c)
pierpaolo.berti@sabes.it+39 0471439716
CONTACTLuigi Cattaneo, Associate professor
luigi.cattaneo@unitn.it+39 0464 808773
PRINCIPAL_INVESTIGATORPier Paolo Berti, MD

Department of Neurosurgery, Hospital of Bolzano (SABES-ASDAA) - L. Boehler street n5 Bolzano, BZ, Italy 39100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026